Parameter | Control | no DR | Mild NPDR | Moderate NPDR | Severe NPDR | PDR | P value* |
---|---|---|---|---|---|---|---|
No. of subjects | 85 | 50 | 25 | 7 | 5 | 10 | Â |
No. of eyes | 162 | 87 | 41 | 11 | 7 | 15 | Â |
Gendera |  |  |  |  |  |  | 0.0012†|
 Female | 63 (74%) | 21 (42%) | 10 (42%) | 2 (33%) | 2 (50%) | 7 (78%) |  |
 Male | 22 (26%) | 29 (58%) | 14 (58%) | 4 (67%) | 2 (50%) | 2 (22%) |  |
Age, y | 51.12 ± 13.06 | 51.38 ± 12.13 | 56.72 ± 9.37 | 54.71 ± 14.42 | 44.80 ± 4.55 | 58.07 ± 9.04 | 0.656 |
MAP, mmHg | 101.76 ± 8.67 | 103.03 ± 13.57 | 105.68 ± 12.90 | 106.28 ± 13.09 | 107.08 ± 18.86 | 101.70 ± 12.91 | 0.239 |
VA, logMAR | 0.04 ± 0.06 | 0.15 ± 0.17 | 0.16 ± 0.17 | 0.28 ± 0.29 | 0.55 ± 0.31 | 0.16 ± 0.12 | < 0.0001 |
OPP, mmHg | 52.06 ± 6.47 | 52.48 ± 9.32 | 55.35 ± 8.60 | 55.12 ± 8.61 | 55.90 ± 11.53 | 55.40 ± 7.76 | 0.312 |
DM duration, m | – | 78.38 ± 69.51 | 138.80 ± 87.17 | 140.00 ± 106.97 | 72.06 ± 56.18 | 168.25 ± 126.46 | 0.0159 |
Hypertension | – | 20 (40%) | 15 (60%) | 3 (42%) | 2 (40%) | 6 (60%) | 0.4706†|
Diabetic nephropathy | – | 6 (6%) | 2 (8%) | 1 (14%) | 1 (20%) | 1 (10%) | 0.4611†|
HbA1c, % | – | 8.42 ± 2.07 | 8.03 ± 1.53 | 9.34 ± 0.80 | 10.04 ± 0 | 8.56 ± 1.77 | 0.2477 |